These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 21624655

  • 1. [Comparative study of the pressure lowering efficacy and variations in the ocular pulse amplitude between fixed combinations of dorzolamide/timolol and brinzolamide/timolol].
    Sánchez-Pulgarín M, Martínez-de-la-Casa JM, García-Feijoó J, Sáenz-Francés F, Santos-Bueso E, Herrero-Vanrell R, García Sánchez J.
    Arch Soc Esp Oftalmol; 2011 May; 86(5):149-53. PubMed ID: 21624655
    [Abstract] [Full Text] [Related]

  • 2. Brinzolamide 1%/timolol 0.5%: safety and efficacy of a new fixed-combination IOP-lowering product for glaucoma.
    Januleviciene I.
    Curr Med Res Opin; 2010 Nov; 26(11):2575-8. PubMed ID: 20868340
    [Abstract] [Full Text] [Related]

  • 3. An eight-week, multicentric, randomized, interventional, open-label, phase 4, parallel comparison of the efficacy and tolerability of the fixed combination of timolol maleate 0.5%/brimonidine tartrate 0.2% versus fixed combination of timolol maleate 0.5%/dorzolamide 2% in patients with elevated intraocular pressure.
    Hatanaka M, Grigera DE, Barbosa WL, Jordao M, Susanna R.
    J Glaucoma; 2008 Dec; 17(8):674-9. PubMed ID: 19092465
    [Abstract] [Full Text] [Related]

  • 4. [Ocular pulse amplitude, intraocular pressure and beta blocker/carbonic anhydrase inhibition in combined therapy of primary open-angle glaucoma].
    Schmidt KG, von Rückmann A, Becker R, Pillunat LE.
    Klin Monbl Augenheilkd; 1999 Dec; 215(6):361-6. PubMed ID: 10637801
    [Abstract] [Full Text] [Related]

  • 5. Intraocular pressure reduction with travoprost/timolol fixed combination, with and without adjunctive brinzolamide, in glaucoma.
    Holló G, Kóthy P.
    Curr Med Res Opin; 2008 Jun; 24(6):1755-61. PubMed ID: 18479590
    [Abstract] [Full Text] [Related]

  • 6. Intraocular pressure-lowering efficacy of brinzolamide 1%/timolol 0.5% fixed combination compared with brinzolamide 1% and timolol 0.5%.
    Kaback M, Scoper SV, Arzeno G, James JE, Hua SY, Salem C, Dickerson JE, Landry TA, Bergamini MV, Brinzolamide 1%/Timolol 0.5% Study Group.
    Ophthalmology; 2008 Oct; 115(10):1728-34, 1734.e1-2. PubMed ID: 18538406
    [Abstract] [Full Text] [Related]

  • 7. Brinzolamide/timolol fixed combination: a new ocular suspension for the treatment of open-angle glaucoma and ocular hypertension.
    Holló G, Bozkurt B, Irkec M.
    Expert Opin Pharmacother; 2009 Aug; 10(12):2015-24. PubMed ID: 19618994
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of the fixed combinations latanoprost/timolol versus dorzolamide/timolol in patients with elevated intraocular pressure.
    Shin DH, Feldman RM, Sheu WP, Fixed Combination Latanoprost/Timolol Study Group.
    Ophthalmology; 2004 Feb; 111(2):276-82. PubMed ID: 15019375
    [Abstract] [Full Text] [Related]

  • 9. Three-month, randomized, parallel-group comparison of brimonidine-timolol versus dorzolamide-timolol fixed-combination therapy.
    Nixon DR, Yan DB, Chartrand JP, Piemontesi RL, Simonyi S, Hollander DA.
    Curr Med Res Opin; 2009 Jul; 25(7):1645-53. PubMed ID: 19476406
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the effects of topical administration of a fixed combination of dorzolamide-timolol to monotherapy with timolol or dorzolamide on IOP, pupil size, and heart rate in glaucomatous dogs.
    Plummer CE, MacKay EO, Gelatt KN.
    Vet Ophthalmol; 2006 Jul; 9(4):245-9. PubMed ID: 16771760
    [Abstract] [Full Text] [Related]

  • 11. The safety and efficacy of brinzolamide 1%/timolol 0.5% fixed combination versus dorzolamide 2%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension.
    Manni G, Denis P, Chew P, Sharpe ED, Orengo-Nania S, Coote MA, Laganovska G, Volksone L, Zeyen T, Filatori I, James J, Aung T.
    J Glaucoma; 2009 Jul; 18(4):293-300. PubMed ID: 19365194
    [Abstract] [Full Text] [Related]

  • 12. Additive intraocular pressure reduction effect of fixed combination of maleate timolol 0.5%/dorzolamide 2% (Cosopt) on monotherapy with latanoprost (Xalatan) in patients with elevated intraocular pressure: a prospective, 4-week, open-label, randomized, controlled clinical trial.
    Hatanaka M, Reis A, Sano ME, Susanna R.
    J Glaucoma; 2010 Jul; 19(5):331-5. PubMed ID: 19730119
    [Abstract] [Full Text] [Related]

  • 13. [Azarga, a new and useful fixed combination in glaucoma treatment].
    Călugăru M, Călugăru D.
    Oftalmologia; 2011 Jul; 55(3):38-46. PubMed ID: 22428291
    [Abstract] [Full Text] [Related]

  • 14. A comparative study of the effects of brinzolamide and dorzolamide on retinal oxygen saturation and ocular microcirculation in patients with primary open-angle glaucoma.
    Siesky B, Harris A, Cantor LB, Kagemann L, Weitzman Y, McCranor L, Marques C, Werne A, Stefansson E.
    Br J Ophthalmol; 2008 Apr; 92(4):500-4. PubMed ID: 18369067
    [Abstract] [Full Text] [Related]

  • 15. Pharmacodynamic equivalence study of two preparations of eye drops containing dorzolamide and timolol in healthy volunteers.
    Gatchev E, Petrov A, Kolev E, Hristova R, Demircheva I, Koytchev R, Richter W, Tegel F, Thyroff-Friesinger U.
    Arzneimittelforschung; 2011 Apr; 61(5):282-6. PubMed ID: 21755811
    [Abstract] [Full Text] [Related]

  • 16. Experience with Cosopt, the fixed combination of timolol and dorzolamide, after switch from free combination of timolol and dorzolamide, in Swiss ophthalmologists' offices.
    Gugleta K, Orgül S, Flammer J.
    Curr Med Res Opin; 2003 Apr; 19(4):330-5. PubMed ID: 12841926
    [Abstract] [Full Text] [Related]

  • 17. Effects of topical 2% dorzolamide hydrochloride alone and in combination with 0.5% timolol maleate on intraocular pressure in normal feline eyes.
    Dietrich UM, Chandler MJ, Cooper T, Vidyashankar A, Chen G.
    Vet Ophthalmol; 2007 Apr; 10 Suppl 1():95-100. PubMed ID: 17973840
    [Abstract] [Full Text] [Related]

  • 18. Effect of timolol, latanoprost, and dorzolamide on circadian IOP in glaucoma or ocular hypertension.
    Orzalesi N, Rossetti L, Invernizzi T, Bottoli A, Autelitano A.
    Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2566-73. PubMed ID: 10937568
    [Abstract] [Full Text] [Related]

  • 19. Effects of dorzolamide 2% added to timolol maleate 0.5% on intraocular pressure, retrobulbar blood flow, and the progression of visual field damage in patients with primary open-angle glaucoma: a single-center, 4-year, open-label study.
    Martínez A, Sánchez M.
    Clin Ther; 2008 Jun; 30(6):1120-34. PubMed ID: 18640468
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the efficacy of betaxolol-brinzolamide and timolol-dorzolamide as suppressors of aqueous humor flow in human subjects.
    Brubaker RF, Ingram CJ, Schoff EO, Nau CB.
    Ophthalmology; 2000 Feb; 107(2):283-7. PubMed ID: 10690826
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.